Family Therapy Training and Implementation Platform (FTTIP) Supplement Study

March 2, 2023 updated by: Training and Implementation Associates

Family Therapy Training and Implementation Platform (FTTIP): An Innovative Web-based Tool for Long-term Practice Improvement Supplement Study

The goal of this observational study is to learn about therapists' and agency leaders' experience with evidenced based treatments and the Family Therapy Training and Implementation Platform (FTTIP).

The main questions it aims to answer are:

  1. What are the perceptions and experiences of the therapists about the process of learning and practicing specific Culturally Informed Flexible Family Based Treatment for Adolescents (CIFFTA) competencies from the platform?
  2. What are therapists' unique experiences related to implementation of the evidenced based treatment (EBT), delivery of competencies learned, and the application of EBT in a real-world context?
  3. What are agency leaders' experiences in facilitating EBTs at their agencies what are the barriers that can be addressed by the organizational readiness work?
  4. What is the experience of the entire agency with the platform, consultation process, perceived cost-benefit, and agency readiness?

Study Overview

Detailed Description

The supplement project will have multiple components that augment the parent study by collecting qualitative data that we can combine with the parent study's quantitative data to better understand the experiences of trainees and agency leaders with the platform.Twenty trainees (randomly selected from the 75 CIFFTA parent study trainees) and 16 agency leaders from the sample of the parent study will be included. The proposed supplement aims to: 1) gather perceptions and experiences of the trainees about the process of learning and practicing specific CIFFTA competencies from the platform (time 1 interview) and later, about their unique experiences related to implementation of the EBT, delivery of competencies learned, and the application of EBT in a real-world context (time 2); and 2) gain a deeper understanding from leaders of their experiences in facilitating EBTs at their agencies, the identification of barriers that can be addressed by the organizational readiness work (time 1), and later regarding their agencies experience with the platform, consultation process, perceived cost-benefit, and agency readiness (at time 2).

Study Type

Observational

Enrollment (Anticipated)

36

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Participants will be selected from therapists and agency leaders that are already enrolled in the parent study (150 counselors and 30 agency leaders).

Description

Inclusion Criteria:

  • Bachelors level counselor with 2 years of experience or Master's level counselors and therapists who have not had family therapy training in the past year and who are broadly representative of the potential trainees in the general population, including educational background and job experience with different client populations (e.g., varied demographics and presenting problems).
  • All therapists must be actively providing treatment to youth and be willing to deliver the family intervention to at least one family during the project period
  • Therapists must be enrolled in the parent grant and be randomized to the FTTIP condition
  • Agency leaders must be enrolled in the parent grant study
  • To be included in the study, agency leaders must have the authority to allocate agency resources (e.g., giving trainees protected time to participate in training activities, allowing smaller caseloads as they begin implementation) and be willing to participate in agency readiness and implementation consultation.

Exclusion Criteria:

  • • We are not limiting inclusion of any group by sex/gender, race, and/or ethnicity

    • Agencies that are unwilling to participate in all study activities, that have nontraditional funding sources (e.g., totally charity funded), or that are so small they cannot assign sufficient counselors to the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Therapists
20 therapists who were already trained will participate in a qualitative interview to gather perceptions and experiences of the therapists about the process of learning and practicing specific CIFFTA competencies from the therapy training platform (time 1 interview) and later, about their unique experiences related to implementation of the Evidenced Based Treatment (EBT), delivery of competencies learned, and the application of EBT in a real-world context (time 2).
Therapists and agency leaders receiving intervention from the main study will participate in qualitative interviews
Agency leaders
16 agency leaders from the main study will participate in qualitative interviews to 2) gain a deeper understanding from leaders of their experiences in facilitating EBTs at their agencies, the identification of barriers that can be addressed by the organizational readiness work (time 1), and later regarding their agencies experience with the platform, consultation process, perceived cost-benefit, and agency readiness (at time 2).
Therapists and agency leaders receiving intervention from the main study will participate in qualitative interviews

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
TIA Therapist Interview Timepoint 1
Time Frame: After 2 weeks given to complete a 20 hour training
Interview to assess perceptions and experiences of the therapists about the process of learning and practicing specific CIFFTA competencies from the platform
After 2 weeks given to complete a 20 hour training
TIA Therapist Interview Timepoint 2
Time Frame: After four months of the implementation of the treatment with a family
Interview to assess therapists' unique experiences related to implementation of the Evidenced Based Treatment, delivery of competencies learned, and the application of EBT in a real-world context
After four months of the implementation of the treatment with a family
TIA Agency leader Interview Timepoint 1
Time Frame: Prior to the start of training or implementation of therapists at the organization
Interview to gain a deeper understanding from leaders of their experiences in facilitating EBTs at their agencies, the identification of barriers that can be addressed by the organizational readiness work
Prior to the start of training or implementation of therapists at the organization
TIA Agency leader Interview Timepoint 2
Time Frame: After four months of treatment implementation at the organization
Interview to assess agencies experience with the platform, consultation process, perceived cost-benefit, and agency readiness
After four months of treatment implementation at the organization

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

April 1, 2023

Primary Completion (Anticipated)

March 1, 2024

Study Completion (Anticipated)

March 1, 2024

Study Registration Dates

First Submitted

March 2, 2023

First Submitted That Met QC Criteria

March 2, 2023

First Posted (Actual)

March 14, 2023

Study Record Updates

Last Update Posted (Actual)

March 14, 2023

Last Update Submitted That Met QC Criteria

March 2, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 3R44MH115547-02S1 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Traditional Face to Face Training

Clinical Trials on Qualitative Interview

Subscribe